Introduction: Cancer Immunology Special Issue-Immunotherapy.
作者信息
Kawakami Yutaka
机构信息
Guest Editor.
出版信息
Int Immunol. 2016 Jul;28(7):317. doi: 10.1093/intimm/dxw028. Epub 2016 Jun 15.
PMID:27313100
Abstract
摘要
相似文献
1
Introduction: Cancer Immunology Special Issue-Immunotherapy.引言：癌症免疫学特刊——免疫疗法。
Int Immunol. 2016 Jul;28(7):317. doi: 10.1093/intimm/dxw028. Epub 2016 Jun 15.
2
Neoantigen heterogeneity: a key driver of immune response and sensitivity to immune checkpoint blockade?新抗原异质性：免疫反应及对免疫检查点阻断敏感性的关键驱动因素？
Immunotherapy. 2016 Jun;8(7):763-6. doi: 10.2217/imt-2016-0064.
3
The present status and future prospects of peptide-based cancer vaccines.基于肽的癌症疫苗的现状与未来前景。
Int Immunol. 2016 Jul;28(7):319-28. doi: 10.1093/intimm/dxw027. Epub 2016 May 28.
4
STING signaling: a key to therapeutic tumor immunity.干扰素基因刺激蛋白信号传导：肿瘤免疫治疗的关键
Immunotherapy. 2018 Jul;10(9):729-731. doi: 10.2217/imt-2018-0064.
5
Coinhibitory Pathways in Immunotherapy for Cancer.癌症免疫治疗中的共抑制途径。
Annu Rev Immunol. 2016 May 20;34:539-73. doi: 10.1146/annurev-immunol-032414-112049. Epub 2016 Feb 25.
6
Part II: Checkpoint inhibitors in cancer therapy.第二部分：癌症治疗中的检查点抑制剂。
Immunotherapy. 2016 Jun;8(7):761-2. doi: 10.2217/imt-2014-0051.
7
The benefits of immunotherapy combinations.免疫疗法联合治疗的益处。
Nature. 2017 Dec 21;552(7685):S67-S69. doi: 10.1038/d41586-017-08702-7.
8
Part I: Checkpoint inhibitors in cancer therapy.第一部分：癌症治疗中的检查点抑制剂。
Immunotherapy. 2016 Jun;8(6):675-6. doi: 10.2217/imt-2016-0051.
9
Novel Immunologic Approaches to Melanoma Treatment.黑色素瘤治疗的新型免疫疗法
Actas Dermosifiliogr. 2017 Oct;108(8):708-720. doi: 10.1016/j.ad.2017.01.017. Epub 2017 May 18.
10
Hiding in Plain Sight: Soluble Immunomodulatory Receptors.藏而不露：可溶性免疫调节受体。
Trends Immunol. 2018 Oct;39(10):771-774. doi: 10.1016/j.it.2018.08.004. Epub 2018 Sep 5.
Zotero 插件